Clinical Trials Directory

Trials / Completed

CompletedNCT03059121

The Cleveland Cardiometabolic Cohort

Observational Study of Cardiometabolic Risk in HIV Infected Subjects After Initiation of Antiretroviral Therapy: The Cleveland Cardiometabolic Cohort

Status
Completed
Phase
Study type
Observational
Enrollment
56 (actual)
Sponsor
University Hospitals Cleveland Medical Center · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

In this observational study, the investigators will examine the changes in body composition in HIV-infected subjects before and after initiation of HIV treatment, and look at the correlations with changes in cardiometabolic indices such as endothelial function and coronary calcium scoring.

Detailed description

The effects of lifestyle factors on body composition changes after antiretroviral therapy (ART) are unknown, and as such, investigators will use this prospective observational cohort to study relationships between lifestyle factors, including diet, physical activity and illicit drug use, with changes in body composition after ART. In addition, the effect of the body fat changes will be correlated to changes in cardiometabolic indices such as endothelial function and coronary calcium scoring.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDual-energy X-ray absorptiometry

Timeline

Start date
2016-09-01
Primary completion
2025-05-19
Completion
2025-05-19
First posted
2017-02-23
Last updated
2026-01-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03059121. Inclusion in this directory is not an endorsement.